A ddPCR-based assay was developed using 116-bp and 247-bp amplicons targeting the 18S rRNA gene to quantify residual host cell DNA in purified rAAV preparations produced in HEK293 cells.
Human Gene Therapy · 6 authors, 1 centre
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
A ddPCR-based assay was developed using 116-bp and 247-bp amplicons targeting the 18S rRNA gene to quantify residual host cell DNA in purified rAAV preparations produced in HEK293 cells.
HEK293 cells were used as the host cell line, and two amplicon sizes (116 bp and 247 bp) targeting the 18S rRNA gene were evaluated. Using ddPCR without DNase treatment, host cell DNA was detected at 2.67–7.41 pg/10^9 vg for the 116-bp amplicon and 1.98–6.26 pg/10^9 vg for the 247-bp amplicon. DNase-resistant fractions ranged from 64.4–69.3% and 58.9–69.2% for the respective amplicons, indicating that DNA impurities are partially encapsidated.